Creighton University School of Medicine, Omaha, Nebraska, United States of America.
Corewell Health Research Institute, Royal Oak, Michigan, United States of America.
PLoS One. 2024 Mar 21;19(3):e0299692. doi: 10.1371/journal.pone.0299692. eCollection 2024.
This study aimed to analyze the prevalence, risk factors, and clinical implications of hemolyzed laboratory samples in the pediatric emergency department (ED), a subject on which existing data remains scarce.
We conducted a multi-site observational cohort analysis of pediatric ED encounters in Metro Detroit, Michigan, United States. The study included participants below 18 years of age who had undergone peripheral intravenous catheter (PIVC) placement and laboratory testing. The primary outcome was the presence of hemolysis, and secondary outcomes included identifying risk factors for hemolysis and assessing the impact of hemolysis on PIVC failure.
Between January 2021 and May 2022, 10,462 ED encounters met inclusion criteria, of which 14.0% showed laboratory evidence of hemolysis. The highest proportion of hemolysis occurred in the infant (age 0-1) population (20.1%). Multivariable regression analysis indicated higher odds of hemolysis for PIVCs placed in the hand/wrist in the toddler (age 2-5) and child (age 6-11) subgroups. PIVCs placed in the hand/wrist also demonstrated higher odds of failure in infants.
Hemolysis in the pediatric ED population is a frequent complication that occurs at similar rates as in adults. PIVCs placed in the hand/wrist were associated with higher odds of hemolysis compared to those placed in the antecubital fossa. Clinicians should consider alternative locations for PIVC placement if clinically appropriate. Further research is needed to better understand the clinical implications of pediatric hemolysis.
本研究旨在分析小儿急诊科(ED)中溶血实验室样本的流行率、风险因素和临床意义,因为现有数据对此仍较为缺乏。
我们在美国密歇根州底特律市进行了一项多站点观察性队列分析,纳入了接受外周静脉置管(PIVC)和实验室检测的 18 岁以下儿科 ED 就诊患者。主要结局为溶血的存在,次要结局包括确定溶血的风险因素以及评估溶血对 PIVC 失败的影响。
2021 年 1 月至 2022 年 5 月,符合纳入标准的 ED 就诊共 10462 例,其中 14.0%的患者存在实验室证据提示溶血。溶血发生率最高的是婴儿(0-1 岁)人群(20.1%)。多变量回归分析表明,在幼儿(2-5 岁)和儿童(6-11 岁)亚组中,PIVC 在手/腕部置管的患者发生溶血的几率更高。在手/腕部置管的 PIVC 也更有可能导致婴儿 PIVC 失败。
小儿 ED 人群中的溶血是一种常见并发症,其发生率与成人相似。与在前臂置管相比,在手/腕部置管的 PIVC 发生溶血的几率更高。如果临床可行,临床医生应考虑其他 PIVC 置管部位。需要进一步研究以更好地了解儿科溶血的临床意义。